Impact of SARS-CoV-2 (COVID-19) Infections on Mental Health Diagnoses in Youth With Chronic Illness

Overview

Journal JAACAP Open

Date 2024 Nov 18

PMID 39552816

Authors

Molly McVoy

Rina Hung

Irina Bransteter

Jaime A Perez

Tracy L Segall

Jessica O Surdam

David W Miller

Jeffrey A Dusek

Martha Sajatovic

Affiliations

Soon will be listed here.

Abstract

Objective: Stressors from the COVID-19 pandemic and limited availability of mental health care services have negatively impacted youth mental health in a significant way. In the first year of the pandemic, global prevalence of anxiety and depression increased by roughly 25% in pediatric populations. While the general trend is clear, this research aimed to explore the added mental health burden of acute COVID-19 on pediatric patients with chronic conditions and describe the differences in mental health outcomes between pediatric patients with 2 common chronic conditions (asthma and diabetes) to better understand specific factors that may increase susceptibility to mental health concerns.

Method: Using the TriNetX database, data were extracted for all pediatric patients (aged 5-17 years) with a positive SARS-CoV-2 infection (COVID-19) within a 1-year time frame (April 7, 2021, to April 6, 2022). These patients were divided into 4 cohorts based on the presence of chronic conditions before COVID-19 infection: diabetes (n = 1,587), asthma (n = 13,217), diabetes plus asthma (n = 626), and neither diabetes nor asthma (n = 104,427). For all cohorts, patients with other chronic illness and previous mental health diagnoses were excluded using relevant codes. After matching for demographics, comorbid conditions, and body mass index, odds ratios (ORs) of the following outcomes were compared between cohorts after 6 months: new psychiatric diagnosis using relevant codes, hospitalization within 1 week, and mortality.

Results: After matching, there were statistically significant differences in outcomes between patients with chronic illness and healthy controls after 6 months. Compared with healthy controls, the asthma cohort OR of developing a new psychiatric diagnosis was 1.4 (95% CI 1.15-1.71, < .001), and the diabetes cohort OR was 1.81 (95% CI 1.11-2.94, = .015). The new psychiatric diagnosis OR of the asthma cohort compared with the diabetes cohort was 0.62 (95% CI 0.39-0.99, = .045), suggesting that patients in the diabetes cohort were particularly susceptible to additional mental health diagnoses after an acute COVID-19 infection.

Conclusion: Compared with healthy controls, pediatric patients with asthma and pediatric patients with diabetes experienced increased odds of developing a new psychiatric diagnosis after an acute COVID-19 infection.

References

Miller G, Coffield E, Leroy Z, Wallin R . Prevalence and Costs of Five Chronic Conditions in Children. J Sch Nurs. 2016; 32(5):357-64. PMC: 5010981. DOI: 10.1177/1059840516641190. View

Zhou Y, Chi J, Lv W, Wang Y . Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2020; 37(2):e3377. PMC: 7361201. DOI: 10.1002/dmrr.3377. View

Fotea S, Ghiciuc C, Stefanescu G, Cianga A, Mihai C, Lupu A . Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics. Diagnostics (Basel). 2023; 13(14). PMC: 10378192. DOI: 10.3390/diagnostics13142436. View

Bez Y, Kompella S, Summerson A, Coffey B . Management of COVID-19 Infection-Associated Flare in an Adolescent with Pediatric Acute Neuropsychiatric Syndrome and Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2022; 32(6):368-371. DOI: 10.1089/cap.2022.29224.bjc. View

Taquet M, Luciano S, Geddes J, Harrison P . Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020; 8(2):130-140. PMC: 7820108. DOI: 10.1016/S2215-0366(20)30462-4. View

. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(13):382-386. PMC: 7119513. DOI: 10.15585/mmwr.mm6913e2. View

Cazzola M, Matera M . Bronchodilators: current and future. Clin Chest Med. 2014; 35(1):191-201. DOI: 10.1016/j.ccm.2013.10.005. View

Nalleballe K, Onteddu S, Sharma R, Dandu V, Brown A, Jasti M . Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020; 88:71-74. PMC: 7297688. DOI: 10.1016/j.bbi.2020.06.020. View

Racine N, McArthur B, Cooke J, Eirich R, Zhu J, Madigan S . Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19: A Meta-analysis. JAMA Pediatr. 2021; 175(11):1142-1150. PMC: 8353576. DOI: 10.1001/jamapediatrics.2021.2482. View

10.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View

11.

Pergolizzi J, LeQuang J, Breve F, Magnusson P, Varrassi G . Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review. Cureus. 2023; 15(1):e33319. PMC: 9894635. DOI: 10.7759/cureus.33319. View

12.

Abrams E, Sinha I, Fernandes R, Hawcutt D . Pediatric asthma and COVID-19: The known, the unknown, and the controversial. Pediatr Pulmonol. 2020; 55(12):3573-3578. PMC: 7675412. DOI: 10.1002/ppul.25117. View

13.

Laires P, Dias S, Gama A, Moniz M, Pedro A, Soares P . The Association Between Chronic Disease and Serious COVID-19 Outcomes and Its Influence on Risk Perception: Survey Study and Database Analysis. JMIR Public Health Surveill. 2021; 7(1):e22794. PMC: 7806339. DOI: 10.2196/22794. View

14.

Grandinetti R, Palazzolo E, Rizzo L, Carbone R, Pisi G, Fainardi V . Impact of SARS-CoV-2 Infection in Children with Asthma and Impact of COVID-19 Vaccination: Current Evidence and Review of the Literature. Microorganisms. 2023; 11(7). PMC: 10383403. DOI: 10.3390/microorganisms11071745. View

15.

Singh S, Roy D, Sinha K, Parveen S, Sharma G, Joshi G . Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations. Psychiatry Res. 2020; 293:113429. PMC: 7444649. DOI: 10.1016/j.psychres.2020.113429. View

16.

Palmon P, Jackson D, Denlinger L . COVID-19 Infections and Asthma. J Allergy Clin Immunol Pract. 2021; 10(3):658-663. PMC: 8613003. DOI: 10.1016/j.jaip.2021.10.072. View

17.

Woo H, Park S, Yon H, Lee S, Koyanagi A, Jacob L . National Trends in Sadness, Suicidality, and COVID-19 Pandemic-Related Risk Factors Among South Korean Adolescents From 2005 to 2021. JAMA Netw Open. 2023; 6(5):e2314838. PMC: 10209749. DOI: 10.1001/jamanetworkopen.2023.14838. View

18.

Chavira D, Ponting C, Ramos G . The impact of COVID-19 on child and adolescent mental health and treatment considerations. Behav Res Ther. 2022; 157:104169. PMC: 9339162. DOI: 10.1016/j.brat.2022.104169. View

19.

Boechat J, Wandalsen G, Kuschnir F, Delgado L . COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health. 2021; 18(3). PMC: 7908623. DOI: 10.3390/ijerph18031093. View

20.

Loomba R, Villarreal E, Farias J, Bronicki R, Flores S . Pediatric Intensive Care Unit Admissions for COVID-19: Insights Using State-Level Data. Int J Pediatr. 2020; 2020:9680905. PMC: 7704189. DOI: 10.1155/2020/9680905. View